Thomas P Miller

  • 19175 Citations
  • 57 h-Index
1978 …2021

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

1984

Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay

Ludwig, R., Alberts, D. S., Miller, T. P. & Salmon, S. E., Apr 1 1984, In : Cancer Chemotherapy And Pharmacology. 12, 3, p. 135-141 7 p.

Research output: Contribution to journalArticle

29 Scopus citations

Phase II trial of bisantrene in patients with intermediate and high grade diffuse non-Hodgkin's lymphomas

Miller, T. P., Jones, S. E., Alberts, D. S. & Mackel, C., Mar 1 1984, In : Investigational New Drugs. 2, 1, p. 75-77 3 p.

Research output: Contribution to journalArticle

2 Scopus citations

Pseudonodular T cell lymphoblastic lymphoma

Schwarte, J. E., Grogan, T. M., Hicks, M. J., Weinrach, R. S. & Miller, T. P., Nov 1984, In : The American journal of medicine. 77, 5, p. 947-949 3 p.

Research output: Contribution to journalArticle

5 Scopus citations
1983
2 Scopus citations

Initial chemotherapy for clinically localized lymphomas of unfavorable histology

Miller, T. P. & Jones, S. E., Jan 1 1983, In : Blood. 62, 2, p. 413-418 6 p.

Research output: Contribution to journalArticle

150 Scopus citations

Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine

Garewal, H. S., Brooks, R. J., Jones, S. E. & Miller, T. P., Jan 1 1983, In : Journal of Clinical Oncology. 1, 12, p. 772-775 4 p.

Research output: Contribution to journalArticle

33 Scopus citations

Treatment of small cell lung cancer with VP-16, vincristine, doxorubicin (Adriamycin), cyclophosphamide (EVAC), and high-dose chest radiotherapy

Goodman, G. E., Miller, T. P., Manning, M. M., Davis, S. L. & McMahon, L. J., Jan 1 1983, In : Unknown Journal. 1, 8, p. 483-488 6 p.

Research output: Contribution to journalArticle

22 Scopus citations
1982

Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): A Southwest Oncology Group study

Miller, T. P., Weick, J. K., Grozea, P. N. & Carlin, D. A., Jan 1 1982, In : Cancer Treatment Reports. 66, 3, p. 553-556 4 p.

Research output: Contribution to journalArticle

11 Scopus citations

Mistaken clinical and pathologic diagnoses of Hodgkin's disease: A Southwest Oncology Group Study

Miller, T. P., Byrne, G. E. & Jones, S. J., Jan 1 1982, In : Cancer Treatment Reports. 66, 4, p. 645-651 7 p.

Research output: Contribution to journalArticle

29 Scopus citations
1 Scopus citations
1980
27 Scopus citations

Is there a role for radiotherapy in localized diffuse lymphomas?

Miller, T. P. & Jones, S. E., May 1980, In : Cancer Chemotherapy And Pharmacology. 4, 2, p. 67-70 4 p.

Research output: Contribution to journalEditorial

15 Scopus citations

Phase II trial of vindesine in breast cancer, lymphoma and other tumors: Future directions

Miller, T. P., Jones, S. E., Chester, A. B. & Dorr, R. T., Sep 1980, In : Cancer Treatment Reviews. 7, SUPPL. 1, p. 81-86 6 p.

Research output: Contribution to journalArticle

9 Scopus citations

Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors

Miller, T. P., Jones, S. E. & Chester, A., Dec 1 1980, In : Cancer Treatment Reports. 64, 8-9, p. 1001-1003 3 p.

Research output: Contribution to journalArticle

8 Scopus citations
1979

CHEMOTHERAPY OF LOCALISED HISTIOCYTIC LYMPHOMA

Miller, T. P. & Jones, S. E., Feb 17 1979, In : The Lancet. 313, 8112, p. 358-360 3 p.

Research output: Contribution to journalArticle

57 Scopus citations

Improved survival for patients with advanced non-small-cell carcinoma of the lung

Miller, T. P., Dec 1 1979, In : Arizona Medicine. 36, 12, p. 893-897 5 p.

Research output: Contribution to journalArticle